Cost-effectiveness of intensive lipid-lowering treatment in secondary cardiovascular prevention in Spain and Germany

被引：0
|
作者：
Taylor, D. C.
Pandya, A.
Thompson, D.
Chu, P.
Graff, J.
LaRosa, J. C.
Grundy, S. M.
Wenger, N. K.
Shepherd, J.
Drummond, M. F.
机构：
[1] i3 Innovus, Medford, MA USA
[2] Pfizer Inc, New York, NY USA
[3] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[4] Univ Texas Dallas, Dallas, TX 75230 USA
[5] Emory Univ, Sch Med, Atlanta, GA USA
[6] Univ Glasgow, Glasgow, Lanark, Scotland
[7] Univ York, York YO10 5DD, N Yorkshire, England
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63644-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A345 / A345
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of intensive lipid-lowering treatment in secondary cardiovascular prevention in spain and germany
    Taylor, D. C. A.
    Pandya, A.
    Thompson, D.
    Chu, P.
    Graff, J.
    LaRosa, J. C.
    Grundy, S. M.
    Shepherd, I.
    Wenger, N. K.
    Drummond, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 125 - 125
  • [2] Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
    Michaeli, Daniel Tobias
    Michaeli, Julia Caroline
    Boch, Tobias
    Michaeli, Thomas
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (04) : 683 - 694
  • [3] Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
    Daniel Tobias Michaeli
    Julia Caroline Michaeli
    Tobias Boch
    Thomas Michaeli
    Cardiovascular Drugs and Therapy, 2023, 37 : 683 - 694
  • [4] Cost-Effectiveness of Intensive Lipid-Lowering in Young Adulthood
    Kohli-Lynch, Ciaran N.
    Bellows, Brandon K.
    Moran, Andrew E.
    Zhang, Yiyi
    Wilkins, John T.
    Allen, Norrina B.
    Lloyd-Jones, Donald M.
    CIRCULATION, 2024, 149
  • [5] Cost-effectiveness of intensive lipid-lowering treatment with atorvastatin 80mg versus 10mg in secondary cardiovascular prevention in the UK
    Taylor, D. C. A.
    Pandya, A.
    Thompson, D.
    Chu, P.
    Graff, J.
    Drummond, M.
    Larosa, J. C.
    Grundy, S. M.
    Shepherd, J.
    Wenger, N. K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 121 - 121
  • [6] Cost-effectiveness of lipid-lowering treatment according to lipid level
    Pilote, L
    Ho, V
    Lavoie, F
    Coupal, L
    Zowall, H
    Grover, SA
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (08) : 681 - 687
  • [7] Cost-effectiveness of lipid-lowering therapy
    Wendland, G
    Klever-Deichert, G
    Lauterbach, K
    HERZ, 2001, 26 (08) : 552 - 560
  • [8] Cost-effectiveness of lipid-lowering therapy
    Visseren, F. L. J.
    NETHERLANDS HEART JOURNAL, 2011, 19 (02) : 59 - 60
  • [9] Cost-effectiveness of intensive lipid-lowering treatment for patients with congestive heart failure in the US
    Rosen, V. M.
    Taylor, D. C. A.
    Parekh, H.
    Pandya, A.
    Thompson, D.
    Kuznik, A.
    Waters, D. D.
    Drummond, M.
    Weinstein, M.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) : S81 - S81
  • [10] Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
    Pletcher, Mark J.
    Lazar, Lawrence
    Bibbins-Domingo, Kirsten
    Moran, Andrew
    Rodondi, Nicolas
    Coxson, Pamela
    Lightwood, James
    Williams, Lawrence
    Goldman, Lee
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (04) : 243 - U42
12345